Drug Type Small molecule drug |
Synonyms Ethyl (R)-N-[2-{[(1-Phenylethyl)amino]carbonyl}phenyl]-2-aminopropionic acid, BB 0322703, BB0322703 |
Target |
Mechanism TRPM8 antagonists(Transient receptor potential cation channel subfamily M member 8 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H24N2O3 |
InChIKeyFWFJKHJQESOSQG-YSSOQSIOSA-N |
CAS Registry1252667-12-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | RU | 13 Feb 2022 |